EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial

Kitti Thammakosol, Chutintorn Sriphrapradang iD

Diabetes, Obesity and Metabolism · 2023-03 · 25 (3) · 815-822

DOI: 10.1111/dom.14929 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 20.12.2022. Verfasst von Kitti Thammakosol und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Diabetes Mellitus, Type 2, Hypokalemia, Hypoglycemia. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To determine the effectiveness and safety of early combination of insulin glargine with intravenous (IV) insulin infusion compared with IV insulin infusion alone in the management of diabetic ketoacidosis (DKA).

Methods

This was a single‐centre, open‐label, randomized controlled trial of adults aged 18 years or older diagnosed with DKA. The ‘early glargine’ group was given subcutaneous insulin glargine 0.3 units/kg within the first 3 hours of DKA diagnosis, in addition to the standard IV insulin infusion. The control group received standard IV insulin treatment only. The primary outcome was the time to DKA resolution. The other outcomes included rebound hyperglycaemia, mortality, hypoglycaemia and hypokalaemia, as well as the length of hospital stay (LOS).

Results

A total of 60 patients (30 patients per group) were enrolled. Most patients (76.7%) had type 2 diabetes. Both groups were similar in baseline characteristics, except for higher serum beta‐hydroxybutyrate and lower pH levels in the early glargine group. The mean ± standard deviation time to DKA resolution in the early glargine group was significantly faster than the control group (9.89 ± 3.81 vs. 12.73 ± 5.37 hours; P = .022). The median (interquartile range) LOS was significantly shorter in the early glargine group than in the control group (4.75 [3.53‐8.96] vs. 15.25 [5.71‐26.38] days; P = .024). The incidence of rebound hyperglycaemia, all‐cause mortality, hypoglycaemia and hypokalaemia was similar between the groups.

Conclusions

Early combination of insulin glargine with IV insulin infusion led to a faster DKA resolution and a shorter LOS, without increasing hypoglycaemia and hypokalaemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic KetoacidosisDiabetes Mellitus, Type 2HypokalemiaHypoglycemiaHyperglycemiaAdultHumansInsulinInsulin GlargineInsulin, Regular, HumanHypoglycemic Agents

Stichwörter der Autor:innen

basal insulindiabetic ketoacidosishypoglycaemiahypokalaemiarebound hyperglycaemiatype 2 diabetes

Substanzen

InsulinInsulin GlargineInsulin, Regular, HumanHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Chutintorn Sriphrapradang

Zitieren

APA

Thammakosol, K., & Sriphrapradang, C. (2023). Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial. Diabetes, Obesity and Metabolism, 25(3), 815-822. https://doi.org/10.1111/dom.14929

Vancouver

Thammakosol K, Sriphrapradang C. Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial. Diabetes, Obesity and Metabolism. 2023;25(3):815-822. doi:10.1111/dom.14929

BibTeX
@article{Thammakosol2023,
  author = {Thammakosol, Kitti and Sriphrapradang, Chutintorn},
  title = {Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2023},
  volume = {25},
  number = {3},
  pages = {815--822},
  doi = {10.1111/dom.14929}
}
Kostenlos starten →